Intra-Individual Comparison of Physiologic [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis
Background: Several studies indicate, particularly in the case of [18F]PSMA-1007, a relatively high rate of detection of ganglia in PSMA PET imaging. Ganglia are an integral part of the sympathetic portion of the autonomous nervous system. To date, no studies have directly compared [68Ga]Ga-PSMA-11...
Main Authors: | Emil Novruzov, Dominik Schmitt, Katalin Mattes-György, Markus Beu, Yuriko Mori, Mardjan Dabir, Jan Philipp Radtke, Günter Niegisch, Peter Albers, Lars Schimmöller, Gerald Antoch, Christina Antke, Frederik L. Giesel, Eduards Mamlins |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/10/2787 |
Similar Items
-
Analysis of Pros and Cons in Using [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
by: Costantina Maisto, et al.
Published: (2022-06-01) -
Primary Staging of Prostate Cancer Patients with [<sup>18</sup>F]PSMA-1007 PET/CT Compared with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT
by: Manuela A. Hoffmann, et al.
Published: (2022-08-01) -
Baseline [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
by: Daniel Groener, et al.
Published: (2023-01-01) -
Comparison of [<sup>18</sup>F]PSMA-1007 with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
by: Manuela A. Hoffmann, et al.
Published: (2022-03-01) -
Impact of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT
by: Daniel Groener, et al.
Published: (2023-07-01)